期刊文献+

hIGF-1腺相关病毒质粒的构建、包装和滴度测定

CONSTRUCTION,PACKAGEAND TITER DETERMINATION OF PAAV/HIGF-1 PLASMID
下载PDF
导出
摘要 目的:构建pAAV/biGF-1载体,并测定pAAV/hIGF-1病毒粒子包装盒病毒滴度。方法:将hIGF- 1基因克隆入pAAV腺病毒相关病毒载体,以HEK293包装细胞包装病毒颗粒,HT1080细胞检测病毒滴度。结果:获得插入方向正确的hIGF-1腺相关病毒载体,HEK293细胞包装得到了1012滴度的病毒上清。结论:成功构建了hIGF-1腺相关病毒载体,并且获得了较高滴度包装病毒颗粒。 Objective:To construct pAAV/hlGF-1 plasmid and determine viral titer.Methods:hIGF-1 cDNA fragment was cloned into pAAV vector. Viral particles were packaged with HEK293 cells and viral titer was determined with HT1080 cells.Results:pAAV/hIGF- 1 plasmid with right inserted direction was obtained. After packaged by HEK293 cells,the viral titer was up to 1012.Condusions:pAVW hIGF-1 plasmid was constructed successfully and higher viral titer was obtained.
出处 《承德医学院学报》 2007年第4期354-357,F0002,共5页 Journal of Chengde Medical University
基金 河北省自然基金项目(C2004000658) 国家教育部重点项目(206171)
关键词 HIGF-1 腺相关病毒载体(AAV) 病毒滴度 hIGF-1 AAV Vtral titer
  • 相关文献

参考文献5

  • 1Ridet JL,Privat A.Gene therapy in the central nervous system:direct versus indirect gene delivery [J].J Neurosci Res, 1995, 42(3):287-293.
  • 2Byun J,Kim SH,Kim JM,et al.Analysis of the relative level of gene expression from different retrovira] vectors used for gene therapy [J].Gene Ther, 1996,3(9):780-788.
  • 3Costantini LC,Bakowska JC,Breakefield XO.Gene therapy inthe CNS[J].GeneTherapy,2000,7: 93-109.
  • 4Ferrari FK,Xiao X,McCarty D.New developments in the generation ofAd-free,high-titer rAAV gene therapy vectors [J].NatMed,1997, 3(11): 1295-1297.
  • 5Xiao X,Li J,SalTlulski RJ.Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus [J] .J Virol, 1998,72(3):2224-2232.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部